Creative Medical Technology Holdings Inc (CELZ) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.97 (+10.07%), Market cap $0.01B, 52-week low–high $1.78 ~ $5.59.
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pa
Financial statements, price targets, institutional (13F) holdings and related news for Creative Medical Technology Holdings Inc are updated in real time on BlackAll Trade.
Creative Medical Technology Holdings Inc trades at $0.97 (+10.07%). Real-time quotes and charts are available on BlackAll Trade.
Creative Medical Technology Holdings Inc has a market cap of about $0.01B.
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and or